Caroline E. Piecuch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Caroline E. Piecuch has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Eva Feldman
Department of Neurology, University of Michigan, Ann Arbor, USA
2 shared publications - Stephen A. Goutman
Department of Neurology, University of Michigan
2 shared publications - Benjamin J. Murdock
Department of Neurology University of Michigan Ann Arbor Michigan USA
1 shared publication - Bhramar Mukherjee
Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA
1 shared publication - Cole H. Pieroni
Department of Neurology and
1 shared publication - Dae-Gyu Jang
Department of Neurology University of Michigan Ann Arbor Michigan USA
1 shared publication
Latest Publications
- 23 January 2024
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 457, 122899
Avocational exposure associations with ALS risk, survival, and phenotype: A Michigan-based case-control study
- 23 January 2024
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 457, 122899
Avocational exposure associations with ALS risk, survival, and phenotype: A Michigan-based case-control study
- Open Access
- 8 June 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (11)
NK cells associate with ALS in a sex- and age-dependent manner
NK cells are innate immune cells implicated in ALS; whether NK cells impact ALS in a sex- and age-specific manner was investigated. Herein, NK cells were depleted in male and female SOD1 G93A ALS mice, survival and neuroinflammation were assessed, and data were stratified by sex. NK cell depletion extended survival in female but not male ALS mice with sex-specific effects on spinal cord microglia. In humans, NK cell numbers, NK cell subpopulations, and NK cell surface markers were examined in prospectively blood collected from subjects with ALS and control subjects; longitudinal changes in these metrics were correlated to revised ALS functional rating scale (ALSFRS-R) slope and stratified by sex and age. Expression of NK cell trafficking and cytotoxicity markers was elevated in subjects with ALS, and changes in CXCR3 + NK cells and 7 trafficking and cytotoxicity markers (CD11a, CD11b, CD38, CX3CR1, NKG2D, NKp30, NKp46) correlated with disease progression. Age affected the associations between ALSFRS-R and markers NKG2D and NKp46, whereas sex impacted the NKp30 association. Collectively, these findings suggest that NK cells contribute to ALS progression in a sex- and age-specific manner and demonstrate that age and sex are critical variables when designing and assessing ALS immunotherapy.
- 8 June 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (11)
Open AccessNK cells associate with ALS in a sex- and age-dependent manner
NK cells are innate immune cells implicated in ALS; whether NK cells impact ALS in a sex- and age-specific manner was investigated. Herein, NK cells were depleted in male and female SOD1 G93A ALS mice, survival and neuroinflammation were assessed, and data were stratified by sex. NK cell depletion extended survival in female but not male ALS mice with sex-specific effects on spinal cord microglia. In humans, NK cell numbers, NK cell subpopulations, and NK cell surface markers were examined in prospectively blood collected from subjects with ALS and control subjects; longitudinal changes in these metrics were correlated to revised ALS functional rating scale (ALSFRS-R) slope and stratified by sex and age. Expression of NK cell trafficking and cytotoxicity markers was elevated in subjects with ALS, and changes in CXCR3 + NK cells and 7 trafficking and cytotoxicity markers (CD11a, CD11b, CD38, CX3CR1, NKG2D, NKp30, NKp46) correlated with disease progression. Age affected the associations between ALSFRS-R and markers NKG2D and NKp46, whereas sex impacted the NKp30 association. Collectively, these findings suggest that NK cells contribute to ALS progression in a sex- and age-specific manner and demonstrate that age and sex are critical variables when designing and assessing ALS immunotherapy.